Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease

NCT01466374 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Placebo
DRUG: Placebo
DRUG: BMS-936557 (Anti-IP-10 Antibody)
DRUG: BMS-936557 (Anti-IP-10 Antibody)
DRUG: BMS-936557 (Anti-IP-10 Antibody)
DRUG: BMS-936557 (Anti-IP-10 Antibody)
DRUG: BMS-936557 (Anti-IP-10 Antibody)

Sponsor

Bristol-Myers Squibb